Research and development - Events
Featured Events
With the fast-evolving nature of AI/ML tool development for small molecule discovery, staying ahead of the curve has become increasingly difficult. The AI Convergence: Small Molecule Discovery Summit is your chance to respond to this industry moment head-on.
Unite with industry leaders such as Insilico Medicine, Psivant Therapeutics, Sanofi, Novo Nordisk, as well as newcomers including Eli Lilly’s TuneLab, Expedition Medicines and Montai Therapeutics.
Featuring applied talks that provide confidence on small molecule discovery innovation from concept to IND, alongside proven wet lab validation and increased probability of success, walk away feeling empowered to advance better, AI-enabled small molecules to patients faster.
Events
Attend the Marcus Evans 29th Edition Strategic Project & Portfolio Management for Pharma conference taking place in Frankfurt, Germany between 26-28 January and join industry leaders, strategists, and innovators for an exclusive event focused on transforming how portfolios are prioritized, managed, and accelerated across the R&D lifecycle.
From strategic portfolio planning and dynamic resource allocation to AI-powered decision support and cross-functional execution, discover the latest approaches driving agility and impact in pharma.
Key Topics Include:
Transformative portfolio management approaches using AI
Strategic Agility in the Age of AI: Leading Pharma Portfolio from Vision to Execution
Bridging the Gap Between Market Objectives and Research Needs
Achieving a strategic…
Attend the Marcus Evans 29th Edition Strategic Project & Portfolio Management for Pharma conference taking place in Frankfurt, Germany between 26-28 January and join industry leaders, strategists, and innovators for an exclusive event focused on transforming how portfolios are prioritized, managed, and accelerated across the R&D lifecycle.
From strategic portfolio planning and dynamic resource allocation to AI-powered decision support and cross-functional execution, discover the latest approaches driving agility and impact in pharma.
Key Topics Include:
Transformative portfolio management approaches using AI
Strategic Agility in the Age of AI: Leading Pharma Portfolio from Vision to Execution
Bridging the Gap Between Market Objectives and Research Needs
Achieving a strategic…
Join us at the forefront of innovation at the Marcus Evans 15th Edition R&D and Innovation Excellence Forum, where industry leaders will explore the latest strategies to optimise investments, streamline decision-making, and accelerate transformation in R&D and Innovation. Dive into practical insights on balancing portfolios, maximising ROI, and aligning innovation with market demands. This event is your gateway to understanding how to drive efficiency, foster cross-functional collaboration, and refine R&D and Innovation processes to stay ahead in an increasingly competitive landscape. Don't miss out on this opportunity to empower your R&D team with the tools and knowledge to thrive in a rapidly evolving market.
Key Topics Include:
Achieving Operational Excellence in…
The Marcus Evans 16th Edition R&D Controlling and Performance Management conference taking place in Amsterdam, Netherlands on 16-18 March, 2026 will tackle into some of the toughest challenges R&D controllers face today: securing funding for projects with uncertain outcomes, making the intangible value of innovation visible, and balancing transparency with the freedom researchers need to create. This conference will guide you through practical tools and real scenarios to transform uncertainty into actionable choices. You’ll learn how to build flexible budgets that withstand change, translate innovation into business value executives can back, and confidently sell R&D as a strategic growth driver.
Attending this premier Marcus Evans conference will enable you to:• Win the…
With the fast-evolving nature of AI/ML tool development for small molecule discovery, staying ahead of the curve has become increasingly difficult. The AI Convergence: Small Molecule Discovery Summit is your chance to respond to this industry moment head-on.
Unite with industry leaders such as Insilico Medicine, Psivant Therapeutics, Sanofi, Novo Nordisk, as well as newcomers including Eli Lilly’s TuneLab, Expedition Medicines and Montai Therapeutics.
Featuring applied talks that provide confidence on small molecule discovery innovation from concept to IND, alongside proven wet lab validation and increased probability of success, walk away feeling empowered to advance better, AI-enabled small molecules to patients faster.
The marcus evans S&OP and IBP for Pharma & Life Science conference taking place on 23-25 March, 2026, in Frankfurt, Germany, will bring together senior leaders in supply chain, finance, and planning to explore how pharmaceutical and life sciences organizations are transforming S&OP/IBP to accelerate decision-making, enhance planning accuracy, and strengthen business alignment.
Key Topics Include:
Transform S&OP into IBP to Connect Strategy, Finance, and Execution
Cross Functional Collaboration – Key for Successful S&OP/IBP
Balance Short- and Long-Term Planning to Enable Strategic Alignment
Leverage AI and Data to Strengthen S&OP and IBP Foundations
Drive Change Management to Advance S&OP and IBP Maturity
Align Portfolio and Demand to Build a Single Planni…
The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models.
Attending this premier Marcus Evans conference will enable you to:
Establish Effective Governance and Decision-making Process within the Alliance
Navigating Data Management from…
The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models.
Attending this premier Marcus Evans conference will enable you to:
Establish Effective Governance and Decision-making Process within the Alliance
Navigating Data Management from…
The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.
The UK Biotech Day is a leading event for the UK life sciences sector, bringing together executives and R&D scientists from pharma, biotech, medtech, techbio, investors, lawyers, patent attorneys, CROs, CDMOs, accountants, bankers, executive search agencies and others. Serving as a global gateway, it also connects the UK ecosystem with international partners to drive strategic collaborations through dealmaking, innovation, networking and finding new clients and partners.
EuroQSAR Symposia are taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.The 24th EuroQSAR Symposium, entitled "Synergizing AI and Multiscale Modeling for Drug Discovery", is organised on behalf of QCMS and is chaired by Jordi Mestres (University of Girona).
The symposium will focus on:
Computational Design of Covalent Drugs
Free Energy and Kinetics of Drug-target Binding
Omics Science in Drug Discovery
Artificial Intelligence and Statistical Learning in Drug Discovery
QSAR and Machine Learning for DM/PK
In silico/in vitro Models for Drug Safety
Virtual Screening Successful Stories
Next-generation Docking: Focus on Conformational Entrop…
